Diagnosis led to determination for leukemia survivor Susan Powers, who turned to a clinical trial to help her reach the goal of holding her future grandchild. When an inquiry about hip pain resulted in a diagnosis of acute myeloid leukemia (AML), Powers&rsquo; daughter, Cheryl Spiler, thought her mother might decide against undergoing treatment because of the experience of Powers&rsquo; husband, who had passed away after cancer treatment five years earlier. &ldquo;I knew all along she would never do what my dad did, and we respected her wishes for that. Whatever she wanted to do, we would do.&rdquo; For Powers, however, the knowledge that Spiler was trying to become pregnant changed her perspective. &ldquo;She pulled back and said, &lsquo;I&rsquo;m going to fight, because I want to be here to rock that baby someday,'&rdquo; Spiler says. Powers&rsquo; vow eventually led her to the OSUCCC &ndash; James, where she agreed to participate in &ldquo;Beat AML,&rdquo; a large clinical trial aimed at advancing treatments for the disease. Powers soon began taking a daily pill to treat her AML. Less than a year later, she was told she was in remission&mdash;and she was able to complete her mission of holding her new grandchild. Powers continues to visit the OSUCCC &ndash; James for follow-ups and to provide updates on the baby that helped save her life. &ldquo;The doctors down there are so cheerful and just make you feel good&mdash;I enjoy going down there just to see them, chat with them. They always ask how the baby is,&rdquo; she says. Learn more about Beat AML and how OSUCCC &ndash; James experts have a leading role in its groundbreaking work.